Sponsor · clinical trials

Mucosa Innovations clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our Spain register with Mucosa Innovations as lead sponsor. Synced 13 Nov 2026

4Current trials

2Recruiting now

0Drugs in these trials

1Trial register

Maintained by Sreepriya Prasannan

MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany

Compiled from ClinicalTrials.gov and CTIS registry records · Synced 13 Nov 2026 · Editorial standards

At a glance

Mucosa Innovations is the lead sponsor of 4 current clinical trials in our Spain register. 2 are recruiting patients now. The most common phase is Not applicable. The most-studied condition is Quality of Life.

ClinicalTrials.gov trials by status

Recruiting250%
Not yet open250%

Trials by phase

Not applicable250%
Observational250%

Clinical trials sponsored by Mucosa Innovations

4 on ClinicalTrials.gov

Study	Phase	Status	Start	Registers
Effect of a Novel Topical Composition on the Incidence of Severe Oral Mucositis in Head & Neck Cancer Radiated Patients and Quality of Life Assessed by PROMs. NCT05635929 · ClinicalTrials.gov ↗ · Oral Mucositis, Quality of Life, Mucositis	Not applicable	Recruiting	2022-10	Spain
Changes in the Impact of Genitourinary Syndrome of Menopause With a Novel Nonhormonal Vulvovaginal Gel Assessed by PROMs. NCT06962345 · ClinicalTrials.gov ↗ · Vulvar Atrophy, Vulvovaginal Signs and Symptoms, Genitourinary Syndrome of Menopause	Not applicable	Recruiting	2024-01	Spain
Retrospective Observational Study of Oral Complications and Quality of Life in Head and Neck Cancer Patients Treated With Radiotherapy or Chemoradiotherapy. NCT07739771 · ClinicalTrials.gov ↗ · Oral Mucositis, Quality of Life, Mucositis	Observational	Not yet open	2026-08	Spain
Retrospective Cohort Study of Symptoms and Quality of Life in Women With Genitourinary Syndrome of Menopause. NCT07737782 · ClinicalTrials.gov ↗ · Vulvar Atrophy, Vulvovaginal Signs and Symptoms, Genitourinary Syndrome of Menopause (GSM)	Observational	Not yet open	2026-07	Spain

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

Conditions in Mucosa Innovations trials

8 conditions

Quality of Life4Oral Mucositis2Mucositis2Pain2Vulvar Atrophy2Vulvovaginal Signs and Symptoms2Genitourinary Syndrome of Menopause1Genitourinary Syndrome of Menopause (GSM)1

By trial register

Register	Trials	Recruiting
Clinical trials in Spain	4	2

A trial with sites in more than one country appears in each of those registers.

Other sponsors in Quality of Life

Sponsor	Trials
Ludwig-Maximilians - University of Munich	4
University Hospital, Clermont-Ferrand	4
Oslo University Hospital	3
Region Örebro County	3
Saglik Bilimleri Universitesi	3
Hospital Universitari de Bellvitge	2
Silimed Industria de Implantes Ltda	2
Hofseth Biocare	1
CEU San Pablo University	1
Université Libre de Bruxelles	1

Sponsors with the most current trials registered for this condition.

Questions about Mucosa Innovations trials

How many clinical trials does Mucosa Innovations sponsor?

Mucosa Innovations is the lead sponsor of 4 current trials on ClinicalTrials.gov in our Spain register, as of the registry sync on 13 November 2026. Completed and withdrawn studies are not counted.

Are Mucosa Innovations trials recruiting?

Yes. 2 of its 4 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 13 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.